Camson Bio Technologies Ltd Financials
Company Logo

Camson Bio Technologies Ltd Financial Statement

Camson Bio Technologies Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2019
Revenue1.19
Operating Expense6.72
Net Profit-7.54
Net Profit Margin-633.61
Earning Per Share-2.51
EBIDTA-5.52
Effective Tax RateTBA

Camson Bio Technologies Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2019
Total Revenue Annual4.98
Operating Expenses Annual21.37
Operating Profit Annual-13.19
Interest Annual1.14
Depreciation6.97
Net Profit Annual-21.90
Tax Annual0.59

Camson Bio Technologies Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2019
Cash Flow at the Beginning0.09
Cash Flow from OperationsTBA
Cash Flow from Investing-0.01
Cash Flow from Financing-0.02
Cash Flow at the End0.06

Camson Bio Technologies Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2019
PBDIT Margin (%)-264.86
PBIT Margin (%)-404.82
PBT Margin (%)-49.60
Net PROFIT Margin (%)-439.76
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)-21.99
Total Debt / Equity (X)0.88
Asset Turnover Ratio (%)0.05

Camson Bio Technologies Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2019
Fixed Assets Annual81.33
Total Current Assets Annual34.96
Non Current Assets Annual87.15
Total Shareholders Funds Annual44.75
Total Assets Annual122.11

Camson Bio Technologies Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Oct 18, 2024, Camson Bio Technologies Ltd has a market capitalization of 20.76 Cr. Value Research classifies it as a Micro-Cap company.
No, Camson Bio Technologies Ltd is not debt-free with a debt-to-equity ratio of 1.11.
In FY 2023 , Camson Bio Technologies Ltd recorded a total revenue of approximately 4.98 Cr marking a significant milestone in the company's financial performance.
Camson Bio Technologies Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.5% and -0.4% annually, respectively..
Camson Bio Technologies Ltd's current PE ratio is -0.95.
Camson Bio Technologies Ltd's ROCE averaged -11.5% from the FY ending March 2017 to 2019, with a median of -13.4%. It peaked at 0.0% in March NaN, reflecting strong capital efficiency over the period..
Camson Bio Technologies Ltd's latest EBIT is Rs. -20.17 Cr, surpassing the average EBIT of Rs. -14.25 Cr over the 5 years..